{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:01:58Z","timestamp":1648519318498},"reference-count":29,"publisher":"Japan Society for Clinical Immunology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2177\/jsci.36.104","type":"journal-article","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T23:01:11Z","timestamp":1367103671000},"page":"104-114","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of nine second- and third-generation anti-cyclic citrullinated peptide antibody assays for the diagnosis of rheumatoid arthritis"],"prefix":"10.2177","volume":"36","author":[{"given":"Nobuhide","family":"HAYASHI","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"KUMAGAI","sequence":"additional","affiliation":[{"name":"The Center for Rheumatic Diseases, Shinko Hospital"},{"name":"Division of Laboratory Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"ONUMA","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"},{"name":"Division of Laboratory Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"UTO","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"},{"name":"Division of Laboratory Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"SUGIYAMA","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, School of Medicine, Keio University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"SAEGUSA","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"KAWANO","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Kobe University Hospital"},{"name":"Division of Laboratory Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Niewold T. B., et al. : Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. <i>QJM<\/i> <b>100<\/b> : 193-201, 2007."},{"key":"2","unstructured":"2) Wiik A. S. : The immune response to citrullinated proteins in patients with rheumatoid arthritis : Genetic, clinical, technical, and epidemiological aspects. <i>Clin Rev Allergy Immunol<\/i>. <b>32<\/b> : 13-22, 2007."},{"key":"3","unstructured":"3) Schellekens G. A., et al. : Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. <i>J Clin Invest<\/i>. <b>101<\/b> : 273-281, 1998."},{"key":"4"},{"key":"5","unstructured":"5) Coenen D., et al. : Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein\/peptide antibodies in the diagnosis of rheumatoid arthritis. <i>Clin Chem<\/i>. <b>53<\/b> : 498-504, 2007."},{"key":"6","unstructured":"6) dos Anjos L. M., et al. : A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. <i>Clin Rheumatol<\/i>. <b>28<\/b> : 153-158, 2009."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Guidelines for the management of rheumatoid arthritis : 2002 update. <i>Arthritis Rheum<\/i> <b>46<\/b> : 328-346, 2002.","DOI":"10.1002\/art.10148"},{"key":"8","unstructured":"8) Tan E. M., et al. : The 1982 revised criteria for the classification of systemic lupus erythematosus. <i>Arthritis Rheum.<\/i> <b>25<\/b> : 1271-1277, 1982."},{"key":"9","unstructured":"9) Vitali C., et al. : Preliminary criteria for the classification of sjogren's syndrome. Results of a prospective concerted action supported by the european community. <i>Arthritis Rheum<\/i>. <b>36<\/b> : 340-347, 1993."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. <i>Arthritis Rheum<\/i>. <b>23<\/b> : 581-590, 1980.","DOI":"10.1002\/art.1780230510"},{"key":"11","unstructured":"11) Bohan A, Peter JB. : Polymyositis and dermatomyositis (first of two parts). <i>N Engl J Med<\/i>. <b>292<\/b> : 344-347, 1975."},{"key":"12","unstructured":"12) Porter J. F., et al. : The AI\/RHEUM knowledge-based computer consultant system in rheumatology. Performance in the diagnosis of 59 connective tissue disease patients from japan. <i>Arthritis Rheum<\/i>. <b>31<\/b> : 219-226, 1988."},{"key":"13","unstructured":"13) Arnett F. C., et al. : The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. <i>Arthritis Rheum<\/i> <b>31<\/b> : 315-324, 1988."},{"key":"14"},{"key":"15"},{"key":"16"},{"key":"17"},{"key":"18"},{"key":"19","unstructured":"19) Wyness S. P., et al. : Performance characteristics of three random access cyclic citrullinated peptide antibody assays. <i>Clin Chim Acta<\/i>. <b>411<\/b> : 428-432, 2010."},{"key":"20","unstructured":"20) Suzuki K., et al. : High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. <i>Scand J Rheumatol<\/i> <b>32<\/b> : 197-204, 2003."},{"key":"21"},{"key":"22"},{"key":"23","unstructured":"23) van Venrooij W. J., et al. : Anti-CCP antibodies : The past, the present and the future. <i>Nature Reviews Rheumatology<\/i>. <b>7<\/b> : 391-398, 2011."},{"key":"24"},{"key":"25"},{"key":"26"},{"key":"27","unstructured":"27) Aggarwal, R., et al. : Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. <i>Arthritis Rheum<\/i> <b>61<\/b> : 1472-1483, 2009."},{"key":"28","unstructured":"28) Bossuyt, X., et al. : Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. <i>Ann Rheum Dis<\/i> <b>68<\/b> : 287-289, 2009."},{"key":"29","unstructured":"29) van der Linden, M. P., et al. : Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. <i>Arthritis Rheum<\/i> <b>60<\/b> : 2232-2241, 2009."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/2\/36_104\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:52:00Z","timestamp":1621486320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/2\/36_104\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.36.104","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}